As a proof of concept, this investigation based on a cell culture model reinforces findings from clinical trials showing that the glycemic control, by reducing the modification of albumin by advanced glycation, may contribute to ameliorating cholesterol removal and inflammation in macrophages—helping to prevent the development of atherosclerosis in DM. Here, ALB is linked to atherosclerosis.